C. Diff

CDC releases HAI Data: How are we doing?

CDC releases HAI Data: How are we doing?

For many years, healthcare institutions have been focused on different ways to decrease HAIs, as federal reimbursement initiatives loomed. So, what does this report card tell us? We've come a long way, baby, but there's still a ways to go.

Invite in infectious disease docs to LTC

Invite in infectious disease docs to LTC

By

If I'm predisposed to being fond of infectious disease physicians, it's because I believe they offer insight beyond that of a general practitioner. This is not to say that a long-term care facility's medical director can't handle a flu outbreak. But it is acknowledging that long-term care staff handles large caseloads with complex patients, and that more facilities should embrace partnerships with an ID physician.

C. diff vaccine moves closer to reality with launch of large Phase III trial

C. diff vaccine moves closer to reality with launch of large Phase III trial

By

A potential Clostridium difficile vaccine performed well in initial tests and now has moved into a large Phase III trial, researchers announced today. The news from developer Sanofi Pasteur raises hopes that the antibiotic-resistant infection can be prevented in long-term care facilities and other settings where it has become a deadly scourge.

Frozen fecal transplants cure C. diff, could be a game-changer, researchers say

By

Fecal transplants to cure Clostridium difficile could become more common, following a trial that successfully used frozen stool specimens, according to researchers at Massachusetts General Hospital.

Budgeting for hand hygiene

Budgeting for hand hygiene

By

One of my former colleagues, who had moved to the healthcare sector from television, shared with me the story of how she began her new job and was told, "Oh, yeah, you can figure out the budget, right?" Administrators with limited budgeting experience might hesitate to make big investments, but when it comes to hand hygiene, spending a little more today could lead to big savings down the line.

An easy way to reduce antibiotics

An easy way to reduce antibiotics

By

It is tempting to run to my internist and beg for an antibiotic to stem what could be a sinus infection, but is more likely, much like the polar vortex, a cold that won't go away. I was reminded of the need to hold back by a new study in JAMA Internal Medicine that reminds us that nearly half the antibiotic prescriptions given for respiratory infections are incorrect, as the majority of the diseases in question are viruses.

C. diff sources 'diverse': study

C. diff sources 'diverse': study

By

New research challenges assumptions about how Clostridium difficile is transmitted.

Fecal matter pills cure C. diff, physician says

By

Pills created from fecal matter are the latest breakthrough in treating Clostridium difficile, according to a doctor in Canada who says he has cured about 30 people this way.

C. diff results stay the same

By

High and low dosages of a popular antibiotic are equally good at combating Clostridium difficile infections, according to a new study.

Sanofi moves to new stage in C. diff  vaccine program

Sanofi moves to new stage in C. diff vaccine program

By

Sanofi Pasteur's vaccine division has started a Phase III clinical trial to evaluate the safety and efficacy of a vaccine for Clostridium difficile.

Study challenges basic assumptions about C. diff transmission

By

A new study contradicts widely held assumptions about how Clostridium difficile infection occurs, which may lead long-term care providers to step up control measures.

Proton-pump inhibitors increase risk of nosocomial C. diff infection: study

By

People who take proton-pump inhibitor medications are at increased risk for developing a Clostridium difficile infection, according to a recently published study that supports previous findings.

Dosage amounts create similar improvement in C. diff cases

By

High and low dosages of a popular antibiotic offer little difference in the outcomes of Clostridium difficile infections, according to a new study.

Toxin identified to diagnose fatal Clostridium difficile cases

By

The bacterial infection Clostridium difficile is most effectively diagnosed through a method called cytotoxin assay, a new study has found.

C. diff therapy put in doubt

C. diff therapy put in doubt

By

Probiotics are not effective in preventing diarrhea associated with Clostridium difficile, according to a large study that calls into question previous findings.

Large study casts doubt on probiotic therapy for C. diff

Large study casts doubt on probiotic therapy for C. diff

By

Probiotics are not effective in preventing diarrhea associated with Clostridium difficile infection, according to a large study that calls into question previous findings. The findings of the U.K. study are especially significant because its size "dwarfs" previous studies, wrote Nick Daneman, M.D., FRCPC, of the University of Toronto.

C. diff spotlight: Vaccine trial and caregiver checklist

C. diff spotlight: Vaccine trial and caregiver checklist

By

Back in June, I declared medication to be the long-term care topic of the summer. But this week, a different topic has stolen the spotlight: Clostridium difficile.

Powerful duo fights C. diff

Powerful duo fights C. diff

By

Antibiotics often aren't enough to combat Clostridium difficile. But when combined with probiotics, or "good" bacteria, the results are striking. The treatment combo lessens the likelihood of C. diff symptoms by 64%, according to a recent study.

FDA responds to provider pressure, backs off stricter control of fecal transplants for C. diff

By

Individuals with treatment-resistant Clostridium difficile can undergo fecal transplants after giving informed consent, the Food and Drug Administration recently announced. This is a victory for providers, who pushed back after the FDA recently announced it would tighten regulations around the transplants.

FDA wants to fast-track treatments for C. diff

By

Clostridium difficile poses a serious public health threat and potential treatments should be fast-tracked, the Food and Drug Administration stated in a newly proposed regulation.

FDA — full of poop?

FDA — full of poop?

By

Every few days I read the Food and Drug Administration (FDA) news to see if there is anything relevant to eldercare that I should be aware of. Recently, I came across an extremely eye-opening item.

Probiotics reduce risk of C. diff symptoms by 64%, researchers say

By

Long-term care facilities dealing with an outbreak of Clostridium difficile have a good chance of reducing symptoms of the infection by administering probiotics, according to a recently released comprehensive review of randomized trials.

Depression tied to C. diff

Depression tied to C. diff

By

Depressed or lonely people are at increased risk of Clostridium difficile infection, according to research in BMC Medicine.

Fecal transplants to treat C. diff now need FDA approval

By

The Food and Drug Administration is moving to tighten regulations around fecal transplants, which research has shown to be an effective treatment for Clostridium difficile infection.

Depressed, lonely seniors are more likely to get C. diff, researchers find

By

People who are depressed or lonely are at increased risk of Clostridium difficile infection, according to recently published research.

Three risk factors could help uncover C. diff. carriers, researchers say

By

Long-term care providers might want to pay special attention to residents with certain recently identified risk factors for Clostridium difficile. These factors are chronic dialysis, recent hospitalization and use of corticosteroids such as prednisone.

Stomach acid drugs raise risk of C. diff

By

Stomach acid is often treated with medications such as Pepcid, but that could put long-term care residents or hospitalized patients at risk for Clostridium difficile, according to a new analysis.

Preventing HAIs in long-term care

Preventing HAIs in long-term care

Preventing the spread of MRSA, CRE and other hospital-acquired infections(HAI's) is quickly becoming a top priority in skilled nursing and long-term care facilities. Yet we often overlook disinfecting procedures on our vital signs monitoring equipment.

C. diff especially deadly for those with kidney disease, researchers find

By

People with end-stage renal disease (ESRD) have a significantly elevated risk of dying from Clostridium difficile infection, according to a recent study.

Limiting use of common antihistamines could reduce C. diff in facilities, researchers say

By

Taking antihistamines such as Tagamet, Pepcid and Zantac increases the risk that people in healthcare settings will be infected with Clostridium difficile, according to a recently published study.

Don't miss any McKnight's news